StockNews.com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)
StockNews.com assumed coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research report released on Sunday. The firm issued a sell rating on the stock. Separately, HC Wainwright restated a buy rating and set a $3.00 price objective on shares of Moleculin Biotech in a report on Thursday, December 14th. Get Our […]
More Stories
Why ‘Holding It In’ Could Damage Your Bladder, Doctors Warn
By George Citroner When the bladder needs relief, many often ignore their body’s cues for the sake of productivity or...
New Orleans Mourns Victims of Truck Attack With Tearful Vigil and Celebration of Life
By The Associated Press NEW ORLEANS—New Orleans mourned, wept, and danced at a vigil Saturday evening along the famous thoroughfare...
Ajinomoto (OTCMKTS:AJINY) Shares Cross Below 50 Day Moving Average – Should You Sell?
Ajinomoto Co., Inc. (OTCMKTS:AJINY – Get Free Report)’s stock price crossed below its 50-day moving average during trading on Friday...
Frenkel Topping Group (LON:FEN) Share Price Passes Below 50 Day Moving Average – Time to Sell?
Frenkel Topping Group Plc (LON:FEN – Get Free Report)’s share price crossed below its 50-day moving average during trading on...
Saker Aviation Services (OTCMKTS:SKAS) Shares Cross Below 50 Day Moving Average – Here’s What Happened
Saker Aviation Services, Inc. (OTCMKTS:SKAS – Get Free Report)’s share price passed below its fifty day moving average during trading...
Kentucky First Federal Bancorp (NASDAQ:KFFB) Stock Price Crosses Below 200-Day Moving Average – Time to Sell?
Kentucky First Federal Bancorp (NASDAQ:KFFB – Get Free Report) shares passed below its 200-day moving average during trading on Friday...